Latest News
-
Daily Relative Strength Index (RSI) In A Bullish Mode of This Pharma Stock; Buy For TP Rs 635-685 -
HDFC Bank Q4 Preview: Net Profit Likely To Grow 56% YoY; Credila Stake Sale To Fuel Earnings -
1:10 Split, Rs 299/Sh Dividend: Tata's Steel Stock Up 11% In 30-Days, Better Than Nifty; PL Says Accumulate -
625% Dividend, 1:10 Split, 3 Bonus; FMCG ITC Makes Big Acquisition Announcement; Stock Target Prices In April -
2:1 Bonus Issue: IT Penny Stock Turned; 1,600 Shares Market Lot Size Revised To 4,800 Shares -
FREE, FREE, FREE! 3:1 Bonus: Pharma Stock Hits Back-To-Back Upper Circuits; 500 Shares To Earn Rs 1,69,500 -
1:10 Stock Split: Below Rs 10, Fertilizer Sector Turned Ex-Split; 8,282% Returns In 5 Years -
Rs 17/Share Dividend: Record Date On April 26; Buy The ICICI Group Stock To Be Eligible? -
Honasa Consumer to Strengthen Operations by Merging Fusion Cosmeceutics and Just4Kids -
Wipro Reports 7.8% Decline in Q4 Net Profit; CEO Highlights Economic Challenges
For Daily Alerts
Rupee weakens again despite RBI measures
The rupee weakened in trade as RBI measures announced on Monday seemed to fade away. The rupee was last trading at Rs 59.28 against the dollar, down 14 paise over Wednesday's close.
The dollar strength was seen across Asian currencies many of them which fell against the dollar. Dealers say that the rupee will continue to remain rangebound going forward despite a slew of measures announced by the RBI.
The Monetary Policy Review due next week would assume significance given worries that the RBI may further drain liquidity from the system by way of CRR hike. This is likely to see some impact on the rupee going forward.
GoodReturns.in
Story first published: Thursday, July 25, 2013, 10:02 [IST]
More From GoodReturns
